Wiley Blackwell

SHERPA: Unknown

People

  1. Perales
    Perales
  2. Jakubowski
    Jakubowski
  3. Giralt
    Giralt
  4. Papanicolaou
    Papanicolaou
  5. Scordo
    Scordo
  6. Yahalom
    Yahalom
  7. Dahi
    Dahi
  8. Imber
    Imber
  9. Palomba
    Palomba
  10. Landau
    Landau

Groups

  1. Bone Marrow Transplant (67)
  2. Center for Hematologic Malignancies (67)
  3. Department of Medicine (67)
  4. Hematologic Malignancies, Division of (64)
  5. Survivorship Research (40)
  6. Hematology-Oncology Fellows (16)
  7. CTCR Scholars (13)
  8. GSK Faculty (13)
  9. Biostatistics Service (12)
  10. Division of Subspecialty Medicine (12)
Search Within
  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (28)
  3. Book Section (6)
  4. Research Letter (1)
Groups
  1. Bone Marrow Transplant (67)
  2. Center for Hematologic Malignancies (67)
  3. Department of Medicine (67)
  4. Hematologic Malignancies, Division of (64)
  5. Survivorship Research (40)
  6. Hematology-Oncology Fellows (16)

More Groups

People
  1. Miguel-Angel Perales (16)
  2. Ann Jakubowski (13)
  3. Sergio Giralt (11)
  4. Craig Sauter (10)
  5. Genovefa Papanicolaou (10)
  6. Joachim Yahalom (9)

More People

Years
  1. 2025 (2)
  2. 2023 (12)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (6)

More Years

Publications
  1. Hematological Oncology (20)
  2. Transplant Infectious Disease (12)
  3. Cancer (10)
  4. American Journal of Transplantation (3)
  5. HLA (3)
  6. Thomas’ Hematopoietic Cell Transplantation: Stem Cell Transplantation. 5th ed (3)

More Publications

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AST-KPCOP survey on clinical practice patterns in kidney transplants for plasma cell dyscrasia
    Meeting Abstract

    Boppana, S.; Blosser, C.; Webber, A.; Gupta, G.; Singh, N.; Master, S.; Parasuraman, R.; Campagnaro, E. L.; Java, A.; Sprangers, B.; more...
    American Journal of Transplantation (2025)

    Fulltext@MSK | Save
  • Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs
    Journal Article

    Burton, H.; Boussi, L.; Nemirovsky, D.; Derkach, A.; Ciervo, J.; Famulare, C.; Chin, K. K.; Valtis, Y.; Yisraeli Salman, M.; Patel, K.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • ZUMA‐24: A phase 2, open-label study of axicabtagene ciloleucel in patients with relapsed/refractory large B‐cell lymphoma given outpatient with corticosteroids
    Meeting Abstract

    Leslie, L.; Tees, M.; Flinn, I. W.; Rodriguez, T. E.; Baird, J. H.; Deol, A.; Mead, M.; Bachier, C.; Rapoport, A. P.; McClune, B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Multicenter experience with radiotherapy for relapse after chimeric antigen receptor T cell therapy in non‐Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H.; Figura, N.; Ladbury, C.; Keit, E. R.; Chew, J.; Fregonese, B.; Silverman, E. A.; Hajj, C.; Shah, G.; Kambhampati, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies
    Meeting Abstract

    Cederquist, G.; Hubbeling, H.; Tringale, K.; Shah, G.; Alarcon Tomas, A.; Shouval, R.; Hajj, C.; Fregonese, B.; Lee, J.; Dahi, P. B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Patterns of disease failure by response to induction therapy in a large cohort of patients with primary central nervous system lymphoma
    Meeting Abstract

    Tringale, K. R.; Yahalom, J.; Scordo, M.; White, C.; Zhang, Z.; Grommes, C.; Imber, B.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Evolving consolidation patterns and modern outcomes for a large longitudinal cohort of primary CNS lymphoma patients
    Meeting Abstract

    Imber, B. S.; Tringale, K.; White, C.; Zhang, Z.; Scordo, M.; Yahalom, J.; Grommes, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Hubbeling, H.; Sarkar, R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Salles, G.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel (LISO‐CEL) versus standard of care (SOC) as second‐line therapy in large B‐cell lymphoma (TRANSFORM study): Subgroup analyses by prior therapy response
    Meeting Abstract

    Nastoupil, L. J.; Kamdar, M.; Chavez, J. C.; Ghesquieres, H.; Ghosh, M.; Holmes, H.; López‐Guillermo, A.; Martínez‐López, J.; Novak, U.; Ribrag, V.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profile in patients receiving CAR T‐cell therapy for aggressive B‐cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Lin, R. J.; Imber, B.; Parascondola, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save